Completed NA INTERVENTIONAL 1-arm NCT02776982

Influence of Central Obesity on the Esophageal Epithelial Barrier

Sponsor: Mayo Clinic

Interventions Bravo ambulatory pH monitor Confocal endomicroscopy Mucosal impedance Research biopsies

Updated 12 times since 2017 Last updated: Jan 25, 2022 Started: Nov 30, 2016 Primary completion: May 16, 2019 Completion: May 16, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02776982, this NA trial focuses on GERD and Gastroesophageal Reflux and remains completed. Sponsored by Mayo Clinic, it has been updated 12 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

12 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Mar 2022 — Jul 2024 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Feb 2021 — Mar 2022 [monthly]

Active Not Recruiting NA
Jan 2021 — Feb 2021 [monthly]

Active Not Recruiting NA

▶ Show 7 earlier versions

Oct 2020 — Jan 2021 [monthly]

Active Not Recruiting NA
Feb 2020 — Oct 2020 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting
Sep 2019 — Feb 2020 [monthly]

Recruiting NA
Jun 2019 — Sep 2019 [monthly]

Recruiting NA
Feb 2019 — Jun 2019 [monthly]

Recruiting NA
Jun 2018 — Feb 2019 [monthly]

Recruiting NA
Jan 2017 — Jun 2018 [monthly]

Recruiting NA

First recorded

Nov 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mayo Clinic

Data source: Mayo Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rochester, United States